ENPP3 and systemic lupus erythematosus: Given the inverse correlation of B10, Treg and ILC2 with SLE disease activity [18,30,31], it is possible that during the pathogenesis of SLE, the disease progression and development leads to the downregulation of the protective B10, Treg and ILC2.